Literature DB >> 8976644

Quantitation of IL-2Rp75 (CD122) expression on mononuclear cells in rheumatic disease.

P Creamer1, N D Hall.   

Abstract

OBJECTIVE: To compare expression of the p75 chain of the interleukin-2 receptor (IL-2Rp75, CD122) on peripheral and synovial mononuclear cells in rheumatoid and non-rheumatoid inflammatory arthritis.
METHODS: Peripheral blood (PBMC) and synovial (SFMC) mononuclear cells were isolated from subjects with rheumatoid arthritis (n = 16) and non-rheumatoid inflammatory arthritis (n = 12). PBMC were isolated from six healthy controls. Expression of CD122 was examined using indirect immunofluorescence and quantitative flow cytometry.
RESULTS: There was no difference in IL-2Rp75 expression on PBMC from rheumatoid arthritis patients, non-rheumatoid arthritis patients, and controls. In subjects with rheumatoid arthritis there was no difference in IL-2Rp75 expression on PBMC and SFMC. However, in the non-rheumatoid arthritis group there was an increase in IL-2Rp75 expression on SFMC compared with PBMC (P = 0.0032). On SFMC there was a greater expression of IL-2Rp75 in non-rheumatoid arthritis than in rheumatoid arthritis (P = 0.0007). Expression was greater on CD8 positive cells and in subjects with shorter duration of disease.
CONCLUSIONS: The p75 chain of the IL-2 receptor, an important T cell activation antigen, is not upregulated in synovial fluid. This appears to be a disease specific defect and provides further support for the concept of "frustrated" or incomplete T cell activation in this disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8976644      PMCID: PMC1010323          DOI: 10.1136/ard.55.11.844

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  15 in total

1.  Measurement of HLA class I expression in ankylosing spondylitis.

Authors:  P Creamer; J Edmonds; J Sullivan; S Matthews
Journal:  Ann Rheum Dis       Date:  1992-10       Impact factor: 19.103

2.  Diminished IL-2-induced gamma-interferon production by unstimulated peripheral-blood lymphocytes in rheumatoid arthritis.

Authors:  F Hasler; J M Dayer
Journal:  Br J Rheumatol       Date:  1988-02

3.  Basis for defective responses of rheumatoid arthritis synovial fluid lymphocytes to anti-CD3 (T3) antibodies.

Authors:  M Lotz; C D Tsoukas; C A Robinson; C A Dinarello; D A Carson; J H Vaughan
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

Review 4.  Role of the endothelium in chronic inflammatory synovitis.

Authors:  M Ziff
Journal:  Arthritis Rheum       Date:  1991-11

Review 5.  How important are T cells in chronic rheumatoid synovitis?

Authors:  G S Firestein; N J Zvaifler
Journal:  Arthritis Rheum       Date:  1990-06

6.  The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells.

Authors:  M Tsudo; C K Goldman; K F Bongiovanni; W C Chan; E F Winton; M Yagita; E A Grimm; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

7.  Modulation of human T cell functions by surface sulphydryl groups: differential effects on IL-2 production and responsiveness.

Authors:  S Smith; C H Brown-Galatola; N D Hall
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

8.  Differential expression of the IL-2 receptor subunits, p55 and p75 on various populations of primary peripheral blood mononuclear cells.

Authors:  Y Ohashi; T Takeshita; K Nagata; S Mori; K Sugamura
Journal:  J Immunol       Date:  1989-12-01       Impact factor: 5.422

9.  The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis.

Authors:  G S Panayi; J S Lanchbury; G H Kingsley
Journal:  Arthritis Rheum       Date:  1992-07

10.  Detection of IL-2 at mRNA and protein levels in synovial infiltrates from inflammatory arthropathies using biotinylated oligonucleotide probes in situ.

Authors:  W M Howell; C J Warren; N J Cook; M I Cawley; J L Smith
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.